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ABSTRACT
Nutritional Supplementation of glucosamine sulfate and chondroitin sulfate are being 
promoted in the treatment of osteoarthritis. Recent research has indicated that gelatin was 
found effective. Moderate exercise is also being advocated. The purpose o f this eight 
week double blind study was to examine the effects of the inexpensive nutritional 
supplement gelatin, in the form of Knox Nutrajoint, and exercise on pain and functional 
activity in 49 subjects with osteoarthritis in one or both knees. Subjects were randomly 
assigned to one o f four groups: placebo, placebo plus exercise, gelatin supplement plus 
exercise and exercise. Exercise consisted o f  a progressive walking program. Results 
were assessed via ANOVA and ANCOVA. No significant difference (p<.05) was found 
for any group on perceived functional ability or pain as measured by the Arthritis Index 
Measurement Tool. Both exercise groups did show a significant improvement in mood 
level. The result o f this study could not support the use o f gelatin supplementation or a 
non supervised walking program for the treatment o f OA.
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CHAPTER 1 
INTRODUCTION
Background to Problem
Osteoarthritis (OA) is a major cause of disabilities among the aging 
population in the United States. This disease is not only painful but also has a 
significant impact on function and quality of life.
As one ages, there are several changes in the body that have an effect on 
joints. There is a reduction in the number of chondrocytes in cartilage. Cartilage 
is broken down at a faster rate than it is being formed (Heft, 1995). Increased age 
is also correlated with decreased absorption o f dietary nutrients (Heuther, 1994). 
Therefore, people may not be absorbing enough of the required nutrients to 
maintain healthy cartilage even if  their diet has not changed. Also, the level of 
activity tends to decrease quite significantly in many individuals as they get older. 
Decreased physical activity has a negative effect on joint cartilage secondary to 
the decrease in nutritional exchange (Hallet, 1994).
Many researchers have correlated moderate exercise programs with 
increased function and reduced pain in people with OA (Fisher, 1993, Schilke, 
1996, Minor, 1989, Ettinger, 1997). Exercise increases general circulation in the 
body. It increases the metabolic rate o f the involved tissues which promotes a 
stronger, healthier tissue and an increased healing rate after injury (Simkin, 1990).
Intermittent compression and decompression along with gliding of articular 
cartilage during moderate exercise activities allows synovial fluid to nourish the 
joint and remove waste products (Hallet, 1994). This movement can also lead to 
thickening and increased resilience in the cartilage. Exercise also leads to 
increased muscle and ligamentous strength that provides stability to the joint 
(Altman, 1990).
Context and Background to Problem
Research is accumulating that dietary supplements such as Glucosamine 
sulfate and chondroitin sulfate (Tapadinhas, 1982, Drovanti, 1980, Vas, 1982, 
D’Ambrosio, 1981), Vitamin C (Kipp, 1996, New, 1997, McAlindon, 1996a) and 
Calcium (New, 1997, McAlindon, 1996b) may decrease pain, improve function 
and even promote regeneration of articular cartilage. A recently published book. 
The Arthritis Cure (1997) examines the benefits o f glucosamine sulfate and 
chondroitin sulfate. This has lead to a surge in sales o f these non-prescription 
nutritional supplements. However, these supplements can be expensive and often 
fail to contain the listed "amount o f ingredient” (Schardt, 1998). There is another 
nutritional supplement, gelatin, that contains the basic amino acid components of 
cartilage, it is cheaper and consistently high in quality.
Gelatin hydrosylate, a dietary supplement, is composed of glycine, proline, 
and other amino acids. These are the components for the biochemical matrix of 
human cartilage. In a double-blinded study by Adam (1991) 10 grams of gelatin 
hydrosylate was administered to 52 patients with a diagnosis o f OA. All patients 
were given the gelatin for a period o f 2 months. The results indicated a significant
decrease in subjective pain as well as a decrease in the amount o f analgesics that 
were consumed. There was no reported change in the patients that received a 
placebo.
The Nabisco Company produces a gelatin product called Nutrajoint® that 
claims to maintain joint and bone health. Knox Nutrajoint® contains gelatin 
hydrosylate, 100% of RDA for Vitamin C, and 15% of RDA for Calcium. This 
nutritional supplement is sold in powder form and can easily be dissolved into a 
beverage for consumption.
In addition to nutritional supplementation, exercise has also been shown to 
have a positive effect on joint health. Recent research regarding the treatment of 
OA has focused on increasing the strength of the knee musculature with resistance 
exercises and/or aerobic exercise programs (Ettinger, 1997, Schilke, 1996, Hallet, 
1994, Fisher, 1993, Minor, 1989). Since most individuals are not aware of the 
appropriate exercise programs, referral to Physical Therapy is becoming an 
important treatment approach to reduce pain and increase function in people with 
OA.
Problem Statement
Increasing numbers o f  people are being referred to physical therapy for 
treatment of OA. However, the number of treatment visits that insurance will 
cover for each patient is decreasing. Studies have shown that moderate exercise 
creates the proper conditions for cartilage to regenerate. However, excessive 
exercise can cause the degeneration of cartilage (Hallet, 1994). Other studies
have shown that nutritional supplementation can decrease pain and increase 
function in patients with OA. Conversely, a lack o f exercise and or proper 
nutrition can cause a degeneration of articular cartilage (McDonough, 1981). 
There are no known studies that compare the effects o f  exercise and nutritional 
supplementation. There are only two studies that have looked at the effects of 
supplementation with gelatin hydrosylate on OA (Adams, 1995, Oberschelp, 
1985).
Aims and Purpose 
The purpose o f this study was to compare the effects o f a placebo 
supplement to 1) exercise alone, 2) a nutritional supplementation of Knox 
Nutrajoint® (which contains gelatin hydrosylate. Vitamin C, and Calcium), and 
3) a nutritional supplementation o f Knox Nutrajoint in combination with exercise 
in the reduction of pain and subjective increase of function in patients with OA of 
the knee.
Hvnothesis/Research Question 
The first hypothesis was that nutritional supplementation of Knox 
Nutrajoint® in combination with a moderate exercise program will be superior to 
the effects o f either exercise alone or Knox Nutrajoint alone when compared to a 
placebo supplement in the reduction of pain and subjective increase in function in 
subjects with OA of the knee(s).
The second hypothesis was that the treatment groups receiving nutritional 
supplementation or exercise would report greater relief of symptoms than the 
group receiving only a placebo.
Significance o f Problem 
In light of recent changes within health care regarding finance and time 
constraints, it is integral that physical therapists research the most efficient and 
cost effective treatments. If  researchers can demonstrate that an inexpensive 
nutritional supplementation in combination with exercise is superior to exercise 
alone or nutritional supplementation alone in relieving pain and dysfunction 
caused by OA then it is in the patient’s best interest and that of the Physical 
Therapy profession to study and promote such discoveries. Not only can this 
have an effect on the efficacy o f treatment but it can also reduce the number of 
Physical Therapy treatments. This could reduce the overall cost o f treatment and 
improve the quality of life for people suffering from OA. Ultimately there could 
be a reduction in the number o f joint replacements for OA sufferers which would 
save time and money for patients, and third party payers, in addition to reducing 
unnecessary pain and dysfunction that patients must endure.
CHAPTER 2
LITERATURE AND CONCEPTUAL FRAMEWORK
Introduction
In the last several years there has been much research done on the cause, 
management and prevention of Osteoarthritis. Recently there has been a push 
towards the use of nutrition or nutritional supplements in the management and 
prevention of OA. This chapter will review the pertinent literature related to 
articular cartilage structure, age-related changes with articular cartilage, the 
pathology of Osteoarthritis and current treatments for this disease.
Conceptual Framework 
The Matrix of Hyaline Cartilage 
Hyaline cartilage covers the surface of bones that form synovial joints. A 
synovial joint is one in which the articulating bones are covered with hyaline 
cartilage and are joined together with ligaments and a capsule lined by a synovial 
membrane that secretes a lubricant into the joint. The hyaline cartilage allows for 
a smooth low friction surface for the articulation between bones. The cartilage is 
composed of a large extracellular matrix that includes both fibrous and nonfibrous 
components as well as a relatively small cellular component. The fibrous 
component of the extracellular matrix is made of elastin and types 11, IX, and XI 
collagens (Jimenez, 1988). Collagen fibers are composed of the amino acids 
proline, lysine and glycine. These fibrous components provide support and 
elasticity to the matrix. The non-fibrous component of the extracellular matrix is
made o f glycoproteins and proteoglycans consisting o f dennatin sulfate, 
chondroitin 4 and 6 sulfate and hyaluronic acid. The glycoproteins and 
proteoglycans attract water and chains o f glycosaminoglycans which hydrate the 
cartilage and provide support for the cellular components (Walker, 1996).
Hyaline cartilage is avascular and aneural. It relies heavily on synovial 
fluid to provide nutrition and remove waste products. As the joint moves the 
compressive force that develops between joint surfaces pushes the fluid out o f the 
cartilage into the joint space. When the compressive forces are removed the fluid 
is reabsorbed into the cartilage. Joint sliding which occurs during joint movement 
may help distribute the synovial fluid and improve its penetration into the 
cartilage. During immobilization o f a joint the synovial fluid can not adequately 
nourish cartilage (McDonough, 1981). Thus, a joint must function and move in 
order to prevent degeneration.
Review of Literature 
Pathophysiology of OA 
Osteoarthritis is a progressive degenerative disease that slowly destroys 
the articular cartilage and adjacent periosteal bone in weight bearing joints and 
frequently used upper extremity joints. Adam (1995) stated that 90% of the 
population is affected by Osteoarthritis by the age o f 70 years. With aging there is 
a significant loss in the amount o f proteoglycan within articular cartilage. This 
makes the cartilage less smooth and more susceptible to erosion and deformation, 
decreasing the shock absorption capabilities. The loss o f the proteoglycans also 
decreases the ability of the cartilage to absorb the nutrient rich synovial fluid. As
the connective tissue matrix continues to weaken the cartilage surface becomes 
irregular and rough. This causes tiny bits o f cartilage to break off and settle in the 
gravity side of the joint and cause irritation to the capsular lining. Formation of 
new type II hyaline collagen is impaired by the aging process due to the altered 
activity of the chondrocytes. Chondrocytes instead begin synthesizing type I and 
type n i collagens. The replacement type I and III collagens are fibrous in nature 
and do not displace and absorb the forces in the joint the same as the normal type 
II collagen. This change in fiber composition has a  significant effect on the 
biomechanical properties of the joint. Due to the abnormal stresses and the 
formation of osteophytes around the joint margin, which stretch the joint capsule, 
the synovial membrane can become inflamed and get increasingly painful over 
time. As the disease progresses, the articular cartilage can erode down to the 
periosteum and cause bony changes and deformation.
The number of type II muscle fibers, phasic muscle fibers, also decrease 
with aging. This causes a decrease in muscle strength around joints. Proper 
muscular and ligamentous support around a joint can minimize the stresses that 
are placed on the articular cartilage. The loss o f muscle mass due to either disuse 
or aging further increases the stress on weight bearing joints leading to further 
progression of OA (Semble, 1990).
Why OA Causes Pain
Several mechanisms have been identified as causes of pain in OA. No 
nocioceptors (pain receptors) have been found in cartilage. Therefore, the pain 
that people with OA experience originates firom other sources. The surrounding
ligamentous capsule and synovial lining are highly vascularized and innervated.
If fragments of cartilage are shed on to synovium they can trigger an 
inflammatory response in the joint capsule. The increased pressure and 
inflammation will stretch the capsule and result in painful symptoms. Crystals of 
calcium pyrophosphate dihydrate and calcium hydroxyapatite shed from deeper 
articular cartilage can also cause an inflammatory response. Enzymes involved in 
the degradation of cartilage are often present in excess in people with OA and 
may also stimulate inflammation. Destruction of articular cartilage may allow 
subchondral bone to become exposed leading to ischemic pain or pain from 
increased vascular pressure. Muscle spasm, which is common with OA can also 
cause pain, especially in the low back (Altman, 1990). Muscle atrophy, caused by 
disuse leads to decreased joint stability, increased biomechanical stress on the 
joint and therefore a further progression of OA (Altman, 1990, Marks, 1993).
Current treatment of Osteoarthritis
Many interventions and coping strategies are used in the treatment of the 
progressive disease of Osteoarthritis. These treatments include prevention, 
symptom reduction, and strategies to halt or even reverse the damage to the joint.
The load that is put on the weight bearing joints plays an important role in 
the development of OA. Depending on the activity, the hip and knee can absorb 
forces 3 to 5 times a person's body weight (Walker, 1996). Increased compressive 
force on the articular cartilage o f the knees due to increased body weight has been 
implicated as a cause of Osteoarthritis (Felson, 1997). Felson also claims that a
weight loss of 10 pounds is correlated with a decrease in 50% of the Osteoarthritis 
symptoms felt in the knee.
Not only can increased loads predispose a joint to Osteoarthritis but 
excessive repetitive activity and/or abnormal stresses due to improper body 
mechanics can also accelerate the degeneration of articular cartilage. Incorrect 
body alignment such as pronated feet, genu varum, and genu valgum create 
excessive forces on the knee and can cause or aggravate Osteoarthritis (Brandt, 
1997). Many of these mal-alignments can be managed with orthotics.
The emotional and psychological coping mechanisms involved in dealing 
with this disease can influence a person's subjective rating o f pain. Because this 
disease is not necessarily visible, people may not receive much support from 
family and friends for the perceived physical pain caused by OA. Psychosocial 
support has been linked with decreased symptoms of OA. Rene (1982) 
discovered that if patients with OA of the knee received a phone call from a 
trained "layperson" once a month, there was a significant decrease in pain in the 
knee, regardless of their stable medical regime.
The use of non-steroidal anti-infiammatory agents (NSAIDS), or 
analgesics for the symptom management of patients with OA is very common.
One problem with using NSAIDS for symptom management in OA is the 
potential for serious side effects with long term use. For example NSAID use is 
associated with increased risk of gastrointestinal complaints, such as ulceration or 
hemorrhage, with increased age. This is significant because the majority o f 
people with OA are the elderly (Brandt, 1997).
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Recent studies have also examined potential negative effects on cartilage 
with long-term NSAID use. The use of NSAIDs for 24 hours significantly 
decreases the activity of prolidase and inhibits collagen biosynthesis in vitro 
(Miltyk, Kama and Patka, 1996). Prolidase is an enzyme that has a crucial role in 
recycling proline for collagen biosynthesis. However, it is questionable if in vitro 
results can be generalized to a patient population. Newman and Ling (1985) 
concluded that long term use of NSAIDs actually accelerates the joint destruction 
in humans. This study, however, was retrospective and therefore also 
questionable. The current research suggesting that NSAIDs may be harmful to 
cartilage, despite their temporary analgesic effects, does not appear conclusive.
Intra-articular corticosteroid injections are another method used to 
decrease pain in Osteoarthritic joints. Hollander (1953) foimd that 87% of 231 
patients had decreased pain in the knee after these injections. Hollander 
operationally defined a successful injection as one in which the patient had relief 
o f pain for a minimum of three days. Although the pain is temporarily relieved, 
other problems occur with excessive use o f this therapy. Corticosteroids have 
been linked with the break down of co lleen  and can lead to joint failure, such as 
tendon rupture, with frequent injections (Gray, 1983). In light o f this, Hollander 
(1953) suggests that when this management tool is utilized the injections should 
be spaced 4 to 6 months apart. Brandt (1997) stated that pain relief after cortisone 
injection may only be temporary. He also pointed out that blocking o f the pain 
transmission may lead to overuse and further breakdown o f the arthritic joint.
II
In contrast to simply managing pain, treatments have recently emerged 
that claim to slow, halt or reverse the process o f cartilage degeneration. 
Lequesne, Brandt and Bellamy (1994) demonstrated that the use o f Disease 
Modifying Osteoarthritis Drugs (DMOADs) decreased proteolytic cartilage 
breakdown and stimulated matrix repair in animals. DMOADs include tissue 
extracts firom animals and also site specific coUagenase inhibitors that can attach 
to the catalytic site of the enzyme. Tissue extracts such as glycosaminoglycan 
polysulfate, (GAGPS) chondroitin-4-sulfate, and chondroitin-6-sulfate have been 
shown to stimulate cartilage synthesis. The use of these tissue extracts has also 
been demonstrated to decrease pain and increase function in patients with OA 
(Kerzberg, 1987, Lopes, 1982, Drovati, 1980, Tapadinhas, 1982).
Another type of DMOAD that has been investigated is gelatin.
Oberschelp (1985) compared three treatments; 1) physical therapy alone, 2) 
Gerontamin (gelatin and retinaol acetate) alone, and 3) a combination o f physical 
therapy and gelatin in 154 subjects diagnosed with chondromalacia patellae, cox 
and gonarthosis, or juvenile spine impairment. Subjects consumed the 
supplement daily for three months. He found that both the Gerontamin alone 
group and the Gerontamin with physical therapy group had a significant decrease 
in pain and an increase in mobility. There were no significant differences 
between these groups. The physical therapy alone group had little effect. He 
concluded that Gerontamin may be beneficial for people when physical therapy is 
not indicated. However, the physical therapy employed in this study involved 
only the use of passive modalities such as iontophoresis, electric current.
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hydrotherapy, ultrasound or massage. Current standards of Physical Therapy for 
OA calls for the use of moderate exercise.
In a double blinded study by Adam (1991) 10 grams of gelatin hydrosylate 
was administered to 52 patients with a diagnosis of OA. The subjects were split 
in to four groups. Three o f  these groups received different forms o f gelatin (10 
grams) and the fourth group received a placebo. Subjects were given the 
supplements for a period o f  2 months. The results indicated a significant decrease 
in subjective pain as well as a decrease in the amount of analgesics that were 
consumed among all of the gelatin groups. There was no change in the patients 
that received a placebo.
A current product that contains the same components as Gerontamine is 
Knox Nutrajoint®. Knox Nutrajoint® claims to contribute to joint health by 
providing the nutritional requirements for articular cartilage. The recommended 
daily amount o f Knox Nutrajoint® contains 10 grams of hydrosylated gelatin, 60 
milligrams of Vitamin C (100% of RDA), and 300 milligrams of Calcium (30% 
RDA). It comes in powder form which is mixed into a preferred beverage for 
consumption.
Physical therapy that combines a balance of strength and aerobic exercise 
has been shown to decrease the same amount of symptoms as NSAIDs (Minor, 
1989). The rational behind the theory of exercise and why it can effectively 
reduce pain will now be discussed.
Benefits o f Exercise in People with Osteoarthritis.
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In the last decade, there has been a paradigm shift regarding the role that 
exercise plays in the management o f Osteoarthritis. Previously, researchers noted 
that arthritis sufferers had decreased muscle strength and physical fimess (Minor, 
1989). However, the consensus was that exercise would increase the rate of 
degeneration of articular cartilage, increasing the likelihood of accelerating the 
cartilage degeneration (Bland and Cooper, 1984).
Exercise puts biomechanical and physiological stress on articular cartilage. 
There are chondrocytes, which are living cells within the cartilage, that adapt to 
the stresses which are imposed on them. These chondrocytes control the 
breakdown and build-up of components o f the cartilage matrix. The stress of 
static loading on cartilage causes decreased chondrocyte synthesis which leads to 
a decrease in the density o f the cartilage. Cartilage motion without compression, 
such as passive range of motion, causes thinning of the articular cartilage. 
However, intermittent compression and decompression of cartilage tends to 
stimulate chondrocyte growth leading to increased stiffiiess of the cartilage (Hallet 
& Andrish, 1994).
In vivo studies, both human and animal, have given researchers insights 
regarding the effects o f exercise on cartilage formation and breakdown.
Strenuous levels of exercise tend to cause break down o f articular cartilage. In 
vivo canine studies show a 6 to 11% reduction of Glucosaminoglycogens (GAGS) 
after strenuous running for 40 weeks (Hallet and Andrish, 1994). The 
Framingham longitudinal study showed that individuals in the highest quartile o f 
exercise at baseline where 3.3 times more likely to develop knee Osteoarthritis
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(Felson, 1997). However, studies on humans have not been able to demonstrate a 
progression in articular breakdown associated with running (Kujala, 1995, Lane, 
1996, Panush, 1986).
Immobilization also leads to decreased articular cartilage and decreased 
GAG concentration. In contrast, cyclic loading of articular cartilage increases the 
movement of higher molecular weight proteins to the joint. These proteins are 
important building blocks of cartilage (Hallet and Andrish, 1994).
In vivo canine studies with moderate running, 4 km a day for 10 weeks, 
showed increased GAG content on femoral condyles, and a 10-28% increase in 
thickness of uncalcified cartilage. Hallet and Andrish (1994) concluded that there 
may be a critical threshold of exercise in which too little or too much is 
detrimental to articular cartilage.
Minor, et. al.(1989) compared the effects of either aerobic walking, 
aerobic aquatic exercise or active range o f motion exercises in 120 patients with 
RA or OA. After 12 weeks, a significant gain was found in aerobic capacity and 
50 ft. walking time in both the aerobic walking and aerobic aquatic exercise 
groups. In addition, these groups also showed decreased depression and anxiety, 
and increased physical activity. The aerobic walking and range o f  motion groups 
reported a significant decrease in pain, however, this was not found with the 
aquatic group. Fisher, et al. (1993) were pioneers in their attempt to 
quantitatively measure a three month physical therapy intervention in patients 
with OA o f the knee. The PT program addressed ROM, muscle strength, pain, 
patient education and functional training. Researchers noted that the muscle
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strength and endurance increased significantly in the hamstrings and quadriceps. 
Functional gains were made in ability to climb stairs, decreased time to walk 50 
ft. and rise from a chair. Subjects also reported less pain with activities o f daily 
living.
Recently, a study was conducted by Ettinger, et. al. (1997) to compare the 
effectiveness o f the previous treatment interventions of aerobic exercise and 
resistance exercise. Based on a self reported disability and pain questionnaire, the 
effects o f structured exercise programs in 365 subjects with OA of the knee were 
analyzed over a period of 18 months. Subjects included males and females age 60 
years or older. A control group was used to account for changes related to health 
education. Researchers concluded that both aerobic exercise and resisted exercise 
interventions were related to a decreased score on disability and knee pain 
questionnaire. Also, the time to complete a 6 minute walk test, ascend and 
descend stairs, lift and carry 10 pounds and transfer in and out o f a car was 
significantly reduced. These effects were reported across sexes and age groups.
Calcium and Vitamin C
Certain levels of Vitamin C, or ascorbic acid, intake may also be important 
in the prevention of Osteoarthritis. In a study using Guinea pigs, decreased 
Vitamin C consumption lead to decreased collagen synthesis in articular cartilage 
and tendons (Kipp, 1996). In human studies, a 300% reduction in risk of 
developing OA was found with both moderate and high consumption of Vitamin 
C. This may be because of the antioxidant effects o f the water soluble ascorbic 
acid on the Reactive Oxygen Species (ROS) which are generated by chondrocytes
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and neutrophils. These ROS can damage hyaluronan, proteoglycans and collagen 
which are important components o f the cartilage matrix. The enzyme used in the 
hydroxylation of proline to hydroxyproline requires ascorbic acid in order to be 
effective. Collagen that does not contain the hydroxylated proline is less stable, 
this is the pathogenesis of connective tissue disorders such as scurvy (Campbell, 
1991).
Calcium supplementation has also been implicated in the prevention of 
OA. One theory is that Osteoarthritis is inversely related to bone mineral density 
(osteoporosis). As bone loses mineral content and becomes softer it may become 
more deformed leading to pain and inflammation. According to McAlindon 
(1996b): “the quality of periarticular bone and its capacity to respond to various 
stresses, including changes in loading force caused by altered biomechanics, may 
influence whether Osteoarthritis stabilizes or progresses.”
It has been well documented that increased calcium supplementation is 
correlated with decreased risk o f  osteoporosis (Compston, 1990). Researchers 
using guinea pigs have also correlated decreased vitamin C supplementation with 
decreased bone density (Kipp, 1996).
Nutrition and Aging 
With aging there is a relative decrease in the ability to absorb nutrients. 
Vitamin deficiencies have been reported in relatively healthy elderly individuals. 
These include Vitamins B-6, B-12, D, Calcium and Zinc. Decreased dietary 
intake o f fat, protein and calories have also been shown with increased age 
(Heuther, 1994). McAlindon (1996b) demonstrated that low blood levels of
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Vitamin D were correlated with decreased joint space and increased osteophyte 
growth. However, no studies could be found that investigate the effect of 
decreased intake or absorption o f basic collagen components, such as proline, 
lysine and glycine, and their relation to Osteoarthritis.
Functional Tests/Outcome Measures 
The Arthritis Impact Measurement Scale 2 (AIMS2) is a 78 item self- 
report questionnaire (Appendix B). It is composed of three factors including pain, 
psychological status, and physical health status. Scales include mobility, walking 
and bending, hand function, arm function, self-care, household, social, family 
support, pain, work, tension, mood, satisfaction, perception of health, and impact 
o f arthritis (Meenan, 1992). This tool was designed specifically for individuals 
with rheumatic diseases. There are between 2 and 6 responses for each question, 
depending on the wording. These are raw scores that are then converted to a scale 
o f 0-10 for statistical purposes (Meenan, Gertman, Mason, and Dimaif, 1982). 
Test-retest reliability for this measurement tool ranged from .78- 96, and internal 
consistency ranged from .74-.96 (Meenan, 1992).
Summarv and Implications for Studv 
Arthritis is a condition of excessive breakdown o f articular cartilage. 
Bioavailability of components for collagen synthesis is an important factor in the 
formation of healthy cartilage. Appropriate building blocks including amino 
acids; glycine, proline and hydroxyproline, and lysine are necessary to maintain 
and repair articular cartilage. Gelatin contains hydroxyproline, hydroxylysine and 
arginine (Adams, 1991). Vitamin C is an important cofactor in collagen synthesis
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and is involved in the hydroxylation o f Type II collagen which promotes the 
stability of collagen (Altman, 1990). Calcium supplementation may help 
maintain bone mineral density (Compston, 1990). Nutritional supplementation 
has been shown to improve the quality of cartilage by increasing the amount of 
essential nutrients required to maintain healthy cartilage and to repair damaged 
cartilage.
Moderate levels of exercise have also been found to decrease pain and 
increase function in people with Osteoarthritis. The intermittent compression, 
decompression and gliding associated with moderate exercise has been shown to 
build and maintain healthy cartilage. It allows for an increased flow of synovial 
fluid into the joint and into the cartilage. Exercise also provides increased 
stability to the joint and stimulates the chondrocytes causing increased synthesis 
o f articular cartilage in response to the increased stress demands.
By combining a nutritional supplementation, Knox Nutrajoint, with 
moderate exercise, the authors of this study hoped to provide optimal conditions 
to allow nutrients to diffuse into the jo in t Theoretically, this combination of 
treatments should outweigh the benefits of either nutritional supplementation or 
exercise alone.
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CHAPTERS 
METHODOLOGY
Design
This experimental study utilized a 2 x 2 factorial design to determine the 
efRcacy of moderate exercise and nutritional supplementation in the treatment of 
people with Osteoarthritis of the knee. The study was double blinded for 
nutritional supplementation only. Subjects were randomly assigned to one of four 
treatment groups for a period o f 8 weeks. One group of subjects was put on a 
progressive walking program and consumed a placebo nutritional supplement 
(maltodextrin). A second group o f subjects consumed a nutritional supplement, 
Knox Nutrajoint®. A third group of subjects consumed Knox Nutrajoint and was 
put on a progressive walking program. The fourth group o f subjects consumed 
only a placebo nutritional supplement (maltodextrin). Each subject completed the 
Arthritis Impact Measurement Scale 2 (Appendix A) before and after the 
treatment program. The pre-test and post-test scores were evaluated to measure 
treatment effects. This design was chosen to determine if there is a significant 
statistical difference between treatment groups and to identify if there is an 
interaction between the independent variables; moderate exercise and the 
nutritional supplementation.
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Population and Sample 
Voluntary subjects were recruited fix>m southeast and southwest Michigan. 
Subjects were obtained from churches, assisted living centers. University faculty 
and staff, through newspaper articles, news and radio broadcasts, ads in Michigan 
newspapers and community postings (Appendix B). After approval was attained 
from the Human Subjects Review Board at Grand Valley University, letters were 
sent out to prospective sites o f subject acquisition to ask for permission to give a 
group presentation. Potential subjects who were interested in addressing knee 
pain secondary to Osteoarthritis were asked to volunteer for this study.
There were 49 participants in this study. Subjects were men (15) and 
women (34) between the ages of 40 and 85, with a mean age of 58.9 years and a 
standard deviation o f 11.7 years. The subjects had been diagnosed with 
Osteoarthritis between zero and 30 years. The average years with diagnosis of 
OA in one or both knees was 9.8 with a standard deviation of 8.21 years.
Potential subjects were given the inclusion/exclusion questionnaire 
(Appendix C) to determine if they were eligible to participate in the study. 
Subjects were excluded if  they had been diagnosed with Diabetes, Rheumatoid 
Arthritis, or Peripheral Vascular Disease, if they were consuming supplements of 
chondroitin sulfate, glucosamine sulfate or gelatin supplements, if they could not 
walk for 20 minutes at a time or had sensory loss in their lower extremities, had 
compromised cognitive status, or other unresolved pathology in the knee that 
would prevent them from taking part in a walking program. Subjects were also 
excluded if they were currently involved in any type o f lower extremity exercise
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program three or more times per week with each session lasting 15 minutes or 
longer in duration.
Instruments/Materials
All of the subjects were evaluated before and after treatment with the 
Arthritis Impact Measurement Scale 2 (AIMS2). This instrument was a 
subjective self-report questionnaire that addressed many issues such as pain and 
ftmctional status. As well as completing the A1MS2, each subject was given log 
sheets to record information on a daily basis (Appendix D). The log sheets 
measured compliance with nutritional supplement consumption and the walking 
program.
The placebo treatment was maltodextrin and the nutritional supplementation was 
Knox Nutrajoint® which contains 10 grams o f hydrosylated gelatin, 60 
milligrams of Vitamin C (100% of RDA), and 300 milligrams o f Calcium (30% 
RDA). Both the placebo and the Knox Nutrajoint came in powder form that was 
mixed into a preferred beverage for consumption.
The Nabisco Corporation for the purpose of this study donated the Knox 
Nutrajoint and the placebo (maltodextrin). Nabisco packaged the Nutrajoint and 
the placebo in identical single serving envelopes. Envelopes were coded either 
“A” or “B” to conceal the identity o f the contents to both the researchers and the 
subjects until the results o f the study were analyzed. The Nabisco Company gave 
a gift of $7,500 to Grand Valley State University to help defiay the costs involved 
in conducting this study. Funding allowed the researchers to increase the number
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of subjects that could be managed in this study by hiring part time research 
assistants and for advertising for potential subjects.
Procedures
Subject recruitment began on June 1, 1998 and ended January 15, 1999. 
Researchers recruited subjects in two major ways. The first method of subject 
recruitment involved going to various senior centers to meet with groups o f 
potential subjects for the study. At the initial meeting, a description of the study 
was provided. Participants were asked to volunteer for the study. All potential 
subjects were given or asked the inclusion/exclusion questionnaire. From the 
results of this questionnaire the researchers determined who was eligible for the 
study. Those volunteers who were not eligible for the study were given an 
arthritis information sheet (Appendix E).
The second method o f subject recruitment involved advertising through 
flyers, newspapers, television news broadcasts and a radio interview. Volunteers 
who called in response to the aforementioned advertisements were read the 
subject questionnaire. Qualified subjects were then asked to participate in the 
study. An initial meeting was then scheduled at a convenient location.
All initial meetings were conducted by researchers; Daniel SchefiFer and 
Anna Power. At this meeting, the subjects were given an informed consent form 
(Appendix F) that was read and signed. The researchers reviewed the consent 
form with each subject and answered all questions. A medical release form with a 
letter explaining the study (Appendix G) as sent to each subject’s physician to 
confirm that they had a diagnosis o f OA in one or both knees. A stamped
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envelope, addressed to the researchers, was enclosed for the physician’s office to 
mail back the diagnosis. Documentation o f a  diagnosis o f Osteoarthritis in one or 
both knees was obtained for each participant in the study.
Subjects then completed the AIMS2. Each subject was randomly assigned 
to one of the four treatment groups by choosing an envelope that contained 
information for that group. An instruction sheet (Appendix H) describing what 
was expected o f their group for the next eight weeks was given to subjects. They 
were asked not to change their diets or take any new supplements for the next 
eight weeks. The first group of subjects were put on a progressive walking 
program and consumed 10 grams (1 packet) o f a placebo nutritional supplement 
(maltodextrin) by mixing it into eight ounces or more of their favorite juice 
beverage. The second group of subjects consumed 10 grams of Knox Nutrajoint 
(1 packet) with eight ounces or more of their favorite juice beverage. The third 
group of subjects consumed a mixture 10 grams (1 packet) o f Knox Nutrajoint 
with eight ounces or more o f their favorite juice beverage as well as being put on 
the progressive walking program. The fourth group o f subjects consumed a 
mixture of 10 grams (1 packet) of a placebo nutritional supplement (maltodextrin) 
with eight ounces or more of their favorite juice. Each subject also received log 
sheets at this time to record their compliance over the coarse o f the study. A 
second copy of the AIMS2 was given to each subject which was to be completed 
immediately at the end of their eight-week participation in the study. The AIMS2 
and the completed log sheets were returned in another stamped envelope 
addressed to the researchers.
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At the end of the initial meeting the researchers supplied the subjects with 
enough Nutrajoint or placebo (maltodextrin) for eight weeks o f consumption. If 
at anytime the subjects ran out o f product they contacted the researchers to be re­
supplied immediately. This happened two times during the course o f the study. 
One time, a  subject moved and lost 2 boxes. Another time, a subject complained 
that one box of envelopes mixed differently than the rest.
A research assistant phoned participants during weeks 1,4 and 8. The 
assistant was blinded to the identity o f the nutritional supplement She used a 
protocol (Appendix I) to ask participants specific questions and remind them to 
fill out their log sheets. If a subject had concerns or questions, the researchers 
would call them back to answer their questions. At the conclusion o f the study, 
the participants were phoned by another research assistant and informed o f the 
identity o f the nutritional supplementation they had been consuming during the 
study. This allowed subjects to continue with the therapeutic intervention if  they 
decided to. After the data was compiled and analyzed, subjects received a  mailing 
letting them know the outcomes o f this study.
The walking program that the exercise groups followed consisted o f three 
sessions per week spread out through the week (Table 3.1). Each subject was 
instructed to walk at a comfortable pace. During the first week each session was 
15 minutes long. Five additional minutes were added each week from the second 
through the fourth week for a total o f 30 minutes of walking per session by the 
fourth week. Thirty-minute sessions were maintained for the remaining four 
weeks.
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Table 3.1 Eight Week Walking Program for Groups 1 and 3
# of days a wk* walking time (minutes)
25
30
30
*the three weekly walking sessions should be spread out through the week
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Chapter 4 
Data Analysis
Techniques of Data Analysis 
All data was entered into a computer text file by a research assistant who 
was blinded to the type o f nutritional supplementation. The SPSS 6.1 Statistics 
Package was used to assess all data. The data underwent ANOVA to determine 
main effects and interactions within and between groups. Alpha levels were set at 
<.05.
The AIMS2 scale has 15 separate subscales that were assessed. These 
included mobility, walking and bending, hand function, arm function, self-care, 
household tasks, social activity, family support, arthritis pain, work related 
activities, level of tension, mood, satisfaction, health perception and arthritis 
impact.
Data Analvsis 
Internal Consistency/Reliability 
The internal consistency of each of these scales were calculated using 
coefficient Alpha. Only nine o f the subscales were found to be reliable. The 
results of the internal consistency calculations are reported in table 4.1.
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For the calculation of overall functionality, the mobility, self care and 
household task subscales were excluded due to little or no variability. The 
internal consistency of the remaining scales ranged from .63 to .94.
The work related activities subscale was also excluded from the overall 
functionality calculation due to missing data. This was caused by the AIMS2 
scale requiring respondents to skip a section if  they were retired, this happened 
with 20 o f the subjects.
Table 4.1: Coefficient Alpha Values for AIMS2 Subscales
Coefficient Alpha
Scale Pretest Post-test
Mobility .56 .33
Walk/Bend .73 .79
Hand .94 .78
Arm .92 .89
Self Care -.11 0
Household 0 0
Social .80 .62
Family .89 .90
Pain .82 .68
Work .86 .63
Tension .93 .85
Mood .88 .92
Satisfaction .84 .81
Overall .78 .82
Analysis of Covariance 
ANCOVA, or Analysis o f Covariance, were conducted for those subscales 
demonstrating reliability. Two subscales. Health Perception and Arthritis Impact, 
that had single response subscales were also analyzed. As each subscale was
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analyzed separately. Alpha was set at .05 divided by the number o f subscales (13), 
.004.
Analysis of Covariance indicated no significant effect for walking and 
bending for the gelatin condition F(3,41) = .59, p=.448 or for the walking 
condition F(3,41) = .48, p=.494. The pretest and posttest means for group 1, 
exercise only, were 5.733, S.D. ± 2.535 and 4.567, S.D. ± 2.597 (See figure 4.1), 
for group 2, placebo, were 3.35, S.D ± 2.729 and 4.15, S.D ±  2.973, for group 3, 
gelatin and exercise, were 4.536, S.D. ± 2.545 and 3.607, S.D. ± 2.422, for group 
4 were 4.8, S.D ± 1.719, and 4.1, S.D. ± 2.601
exercise only placebo exercise and gelatin only
gelatin
(Pretest 
I Posttest
Figure 4.1: Mean Scores for Walking and Bending Subscale.
Analysis of Covariance revealed a significant effect for level o f mood in 
both the exercise groups F(3,41) =9.09, p=.004. No significant effect was noted 
for the gelatin condition F (3 ,41) = 1.25, p=.270. The pretest and posttest means 
for the exercise only group were 3.033, S.D. ±2.125 and 2.300, S.D. ±2.210 (See 
Figure 4.2), for the placebo group were 2.45, S.D ± 2.034 and 3.10, S.D ± 1.969,
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for the exercise and gelatin group were 2.143, SJ3. ±  1.447 and 1.786, S.D. ±
1.805, for the gelatin only group were 1.85, S.D ±  .937, and 1.700, S.D. ± .919.
g  Pretest 
Posttest
exercise only placet» exercise and gelatin only 
gelatin
Figure 4.2: Mean Scores for Mood Subscale
Analysis o f Covariance revealed no significant effect on pain for the 
Exercise condition F(3,41) = 1.18, p=.285. There was no significant effect for 
the gelatin condition F(3,41) = 1.68, p = .202. The pretest and posttest means for 
the exercise group were 5.567, S.D. ± 2.086 and 3.967, S.D. ± 1.968. (See Figure 
4.3), for the placebo group were 5.50, S.D ± 2,273 and 4.40, S.D ± 2.633, for the 
exercise and gelatin group were 4.643, S.D. ± 2.033 and 3.786, S.D. ±1.862, for 
group gelatin only group were 5.20, S.D ± 1.829, and 3.500, S.D. ± 1.528.
Analysis o f Covariance revealed no significant effect on work related 
activities for the Exercise condition F(3,20) = 0, p=.997. There was no 
significant effect for the gelatin condition F(3,20) = .54, p = .473. The pretest and 
posttest means for the exercise group were 4.306, S.D. ± 4.446 and 2.986, S.D. ± 
4.155 (See Figure 4.4), for the placebo group were .714, S.D ± .431 and .714, S.D 
± .759, for the exercise and gelatin group were 2.109, ST). ± 2.692 and 1,250,
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S.D. ±1.157. The pretest and posttest means for the gelatin only group were 
1.406, S.D ± 1.288, and .625, ST). ± .510.
^Pretest
exercise only placebo exercise and gelatin only
gelatin
Figure 43 : Mean Scores for A rthritis Pain Subscale
Analysis of Covariance revealed no significant effect on level of 
satisfaction for the Exercise condition F(3,41) = .42, p=.520. There was no 
significant effect for the gelatin condition F (3 ,41) = .61, p = .440. The pretest and 
posttest means for the exercise group were 3.583, S.D. ± 2.139 and 2.528, S.D. ±
1.467 (See figure 4.5), for the placebo group were 2.979, S.D ± 2.282 and 2.729, 
S.D ± 2.392, for the exercise and gelatin group were 2.515, S.D. ± 1.633 and 
2.381, S.D. ±1.155, for the gelatin only group were 3.125, S.D ± .977 and .2.625, 
S.D.± 1.996.
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|P te test 
■ Posttest j
exercise only placebo exercise and gelatin only
gelatin
Figure 4.4: Mean Scores for W ork Related Subscale
B a I g  Pretest ■ Posttest I
exercise only placet» exercise and gelatin only
gelatin
Figure 4.5: Mean Scores for A rthritis Satisfaction Subscale
The Analysis o f Covariance for overall Arthritis Impact was not 
significant for the exercise condition F(3,41)= 4.05, p=.325. The gelatin 
condition was also not found to be significant F(3,41) = 10.68, p=.l 14. The 
reliability Coefficient was found to be .8193 for this subscale. The pretest and
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posttest means for the exercise group were 5.000, S JD. ± 2.673 and 3.333, S.D. ± 
3.086 (See Figure 4.6), for the placebo group were 5.250, S.D ±2.189 and 3.500, 
SJ3 ± 3.375, for the exercise and gelatin group were 4.107, S J). ± 2.322 and 
3.393, S.D. ± 1.862, for the placebo group were 3.750, S.D ± 2.13 and 3.000, S.D. 
±2.297.
|Pretest
■Posttesti
exercise only placebo exercise and gelatin only
gelatin
Figure 4.6: Mean Scores for Arthritis impact
The Analysis of Covariance for overall Functional Capacity was not 
significant for the exercise condition F (3 ,41)= .11, p=.662. The gelatin condition 
was also not found to be significant F(3 ,41) = .50, p=.86. The pretest and posttest 
means for the exercise group were 3.777, S.D. ± 1.023 and 3.116, S.D. ± 1.047 
(See Figure 4.7), for the placebo group were 3.168, S.D ± 1.511 and 3.034, S.D ± 
1.721, for the exercise and gelatin group were 2.880, S.D. ± 1.041 and 2.672, S.D. 
± .897, for the gelatin only group were 2.934, S.D ± .702 and 2.658, S.D. ± 1.056.
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exercise only placet» exercise and gelatin only
gelatin
Figure 4.7 Mean Scores for Overall functional Capacity Subscale
An analysis o f  Variance was conducted using the Pain rating scales that 
subjects filled out on their log sheets. The average pain ratings of week 1, week 4 
and week 8 were compared. The average pain rating across all four treatment 
conditions decreased significantly F(82.2) = 10.61, p=.000. However, there was 
no significant main effects within treatment conditions; gelatin, F(82,2) = .83, 
p=.442, or exercise F(82,2)=.62, p=.542 (See Table 4.2).
Table 4.2 Mean Pain Ratings for Each Group.
Week 1 mean Week 4 mean Week 8 mean
Placebo 4.00 3.60 3.20
Gelatin 4.50 3.917 3.167
Exercise 4.273 3.636 3.455
Exercise and Gelatin 3.333 3.250 2.500
Entire Sample 4.022 3.600 3.067
Standard Deviation 2.190 2.093 1.924
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Hypothesis and Research Question Results 
The first hypothesis was that nutritional supplementation o f Knox 
Nutrajoint® in combination with a moderate exercise program would be superior 
to the effects o f either exercise alone or Knox Nutrajoint alone when compared to 
a placebo supplement in the reduction of pain and subjective increase in function 
in subjects with OA o f the knee(s). This was not supported by the results of this 
study.
The second hypothesis was that the treatment groups receiving nutritional 
supplementation or exercise would report greater relief o f symptoms than the 
group receiving only a placebo. This was not supported by the results of this 
study.
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Chapter 5
Discussion o f  Findings
The purpose of this study was to compare the effects of a placebo 
supplement to 1) exercise alone, 2) a nutritional supplementation o f Knox 
Nutrajoint® (which contains gelatin hydrosylate. Vitamin C, and Calcium), and 
3) a nutritional supplementation o f Knox Nutrajoint in combination with exercise 
in the reduction of pain and subjective increase o f function in patients with OA of 
the knee.
It is well documented in the literature that exercise can produce 
significant improvement on both subjective and objective functional testing in 
people with OA. The mechanism o f cartilage regeneration has also been 
supported by clinically controlled studies. According to Hallet (1994), articular 
cartilage and subchondral bone will adapt to increased mechanical stresses by an 
increase in thickness. However, if the load is excessive, the cartilage will 
deteriorate instead o f regenerate. Therefore, it is important not to exceed the 
threshold at which cartilage will begin to deteriorate. Theoretically, it is 
necessary to have the appropriate amount o f chondrocytes in the cartilage to assist 
in regenerating the cartilage matrix when prescribing exercise treatment.
According to previous research on exercise, the authors expected to find a 
significant effect on the reduction of pain and increase in function with those
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individuals in the exercise conditions o f this study. All o f the other exercise 
studies demonstrating an increase in functional variables had physical therapists 
or assistants supervise the exercise program (Kovar, 1992; Fisher, 1993; Fisher, 
1989). Unlike other studies that looked at the effects of exercise on OA, this 
study had no formal supervision o f the subjects’ exercise program to determine if 
participants reaching a therapeutic level. Compliance was based on self-report 
only. The lack of significant findings in functional variables could be attributed 
to a lack of supervision.
Another possibility was that eight weeks was not a long enough time 
period to see significant effects of a non supervised home walking program or 
nutritional supplementation. Previous research investigating exercise on OA of 
the knee has been 3 to 18 months in duration (Minor, 1989, Fisher, 1993, Ettinger, 
1997). Oberschelp (1985) investigated gelatin supplementation for 3 months.
Another factor that may have contributed to the lack of significant 
improvement of the exercising groups over non exercise groups was the variation 
in stage of arthritic degeneration in each subjects’ knees. Because there was no 
control for the stage or level of arthritis, there was no way to determine if  a 
subject had enough chondrocytes remaining in their knee for effective 
regeneration of the cartilage.
Neither the gelatin condition nor the exercise condition demonstrated any 
statistical significance in the comparative reduction of pain or increase in 
function. Previous studies that were done on gelatin have demonstrated some 
significant results in mobility and pain status (Adams, 1991, Oberschelp, 1985).
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However, most o f these studies lacked appropriate controls and used poor 
measurement tools. The only double blind placebo study that reported significant 
effects o f gelatin on the reduction of pain was by Adams (1991). This study relied 
on subjective ordinal data and utilized only a chi-square analysis for their 
statistics.
The results o f this study did not support the findings reported in the above 
gelatin studies. Previous gelatin studies utilized chi-squared tests whereas this 
study used the more statistically powerful ANOVA and ANCOVA. The results of 
this study, coupled with the use o f parametric statistics, may imply that a type 1 
error could have occurred in the previous studies.
All subjects, regardless of the group they were in, demonstrated an equal 
decrease in perceived pain scores between weeks one and eight of the study.
These results could be attributed to the placebo effect since the subjects were 
blinded to the type of nutritional supplement that they received.
Rene (1982) discovered that if patients with OA of the knee received a 
phone call firom a trained "layperson" once a month, there was a significant 
decrease in pain in the knee, regardless of their stable medical regime. This 
phenomenon could explain why all of the treatment groups had a decrease in pain, 
as they were called in week one, week four and week eight during their 
participation in this study.
The exercise group did exhibit a statistically significant increase in mood 
compared to the non exercise groups. The increase in wellness and overall well
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being scores had been found to increase in exercise groups in other studies as well 
(Minor, 1989; Kovar, 1992).
Application o f  practice 
There is an abundance o f research using ANOVA and measures with strong 
validity and reliability that demonstrate the efficacy of a well controlled and 
supervised exercise program on the treatment o f OA (Minor, 1989, Ettinger, 1997, 
Fischer, 1993). There is also some evidence to recommend gelatin 
supplementation (Adams, 1991, Oberschelp, 1985). However, the results of this 
study could not support the recommended use o f gelatin supplementation or an 
unsupervised walking program for the treatment o f osteoarthritis of the knee.
Limitations
This study did not control for the stage or the severity of arthritic 
degeneration that each subject had. Nor was the diagnosis o f Osteoarthritis 
classified as to the specific type patellofemoral, tricompartmental or 
unicompartmental. The stage of arthritis has been shown in other studies to be an 
important indicator o f success of nutritional intervention. Incident arthritis, or 
arthritis caused by trauma was only controlled for by excluding individuals under 
40 years o f age as they seem to have a higher incidence of this form o f arthritis.
One o f the most significant limitations o f this study was the lack of control 
for the subject’s diet. Other than documenting estimated calcium and caffeine 
intake in the logbook, there were no regulations on each subject’s diet. This could 
have effected the results if  any of the subjects radically change their diet during
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the course o f the study. Subjects that began to consume high amounts o f  Vitamin 
C or products containing gelatin, would have changed the controlled amount of 
supplementation that they were receiving each day. The authors of this study 
attempted to control for this by asking subjects to maintain their current diet and 
to refrain from adding any additional supplements for eight weeks. There were 
also no baseline diet requirements or inclusion/exclusion criteria before the 
intervention. This may have been relevant since the researchers were basing the 
theoretical need for supplementation on the lack of proper amounts within the 
person’s diet
This study did not control for the occupations and day to day physical 
demands of each of the subjects. Determining the correct amount of physical 
activity to promote joint healing is important in managing OA. Because the 
subjects were not being asked to control the amount of physical activity outside 
the treatment protocol, some may have exceeded the amount of physical activity 
that would foster improvement and produced some degree of pain and 
inflammation. Others may not have had an adequate amount of activity to 
stimulate sufficient improvement in the cartilage matrix to show any significant 
change in pain or function. This could also have affected the outcome o f this 
study.
Although the amount of pain medication was monitored, it could have 
been a confounding variable with respect to pain reduction. Other orthopedic 
dysfunction at the ankle or hip was not controlled for as the only requirement was 
walking time of 15 minutes or more and no previous surgery within 6 months.
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Another limitation to this study was the use of only subjective self-report 
measurement outcomes. Also, there was no formal cognitive measure, which may 
have been important for a purely subjective outcome measure which required 
completion of a detailed questionnaire. The results were subject to self-report 
honestly and compliance.
The length of the study was only eight weeks, which is generally accepted 
to be the minimal amount of time to report subjective change in pain and function 
with gelatin supplementation. It may have proved more significant had the length 
of the study been increased to 6 months or more to allow for a plateau effect 
Another factor that might have affected some subjects’ responses to 
Nutrajoint was that they were not excluded if they had tried chondroitin sulfate, 
glucosamine sulfate or gelatin in the recent past. It is estimated that 20-50% of 
the population does not respond to chondroitin sulfate or glucosamine sulfate 
(Schardt, 1998). It is unknown if  this applies to gelatin supplementation with the 
small sample sizes in this study, 11 to 12 subjects per group, a 20-50% non 
response level to gelatin supplementation could dramatically effect the results.
Familial disposition for arthritis was not investigated. There may be a 
genetic component to arthritis that responds differently to nutritional intervention. 
And last of all, by limiting the focus of this research to the knee, the results of this 
intervention may not be applicable to other arthritic joints, especially non weight 
bearing joints.
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Suggestions for Further Research/Modifications
Modifications to this study should include the use of a shorter subjective 
measurement test. The AIMS2 took up to an hour to complete in several cases. 
Advising patients to consume the supplementation after eating a meal may have 
reduced stomach discomfort experienced by a few of the volunteers. Also, the 
diagnosis of renal dysfunction should have been added to the exclusion criteria 
due to the inability to tolerate higher levels of protein that gelatin contains.
More research needs to be done in the investigation of gelatin and exercise 
on arthritis. Suggestions for future research include comparing the effect of 
glucosamine sulfate to that o f gelatin on arthritis. The stage o f the arthritis should 
also be controlled for in order to determine the most effective or least effective 
time in the progression of OA for nutritional intervention. The exercise 
component should be treated as one of the controlled variables but not as an 
imposed control as it limited the amount of subjects that qualified for this study 
by 50%. Larger sample sizes should also be investigated. Also, the response of 
other arthritic joints to exercise and nutritional supplementation should be 
examined. The duration o f this type of study should be increased and the type of 
exercise could be tailored towards the current activity level o f each subject to 
insure that therapeutic levels are attained. A follow up study should be considered 
as well to examine any long-term benefits of nutritional supplementation.
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Conclusion/Summary 
Despite significant findings in the literature that support the benefits of 
gelatin supplementation and exercise in the treatment o f  OA, the results o f  this 
study did not support the beneficial effects o f either gelatin supplementation or of 
an unsupervised walking program in the treatment of OA o f the knee in people 
over the age o f 40 years. The data indicted that there was a significant 
improvement in the self reported mood level in the exercise groups when 
compared to non exercise groups. There was a significant reduction in the 
perceived pain scores across all four treatment groups. Further study involving 
more subjects, better supervision of exercise, a longer time interval and a less time 
consuming subject self assessment tool is recommended.
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Adm#_
Card #1
1-4/
5-61
It*
ARTHRITIS IMPACT MEASUREMENT SCALES 2
(AIMS2)
Instructions: Please answer the following questions about your health. Most questions ask about your health during the 
past month. There are no right or wrong answers to the questions and most can be answered with a simple 
check (O - Please answer every question.
Please begin by providing the following information about yourself.
NAME:
ADDRESS:
Number Street Apt;*
City State Zip Code
PHONE: DATE:
Area Code Number Month Day Year
AIMS2 Copyright 1990 Boston University
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Please check (O  the most ^ propriété answer for each question.
These questions refer to MOBILITY LEVEL.
All Most Some Few No
DURING THE PAST MONTH ... Days Days Days Days Days
(I) (2) (3) (4) (5)
1. How often were you physical able to drive a car
or use public transportation?           8/
2. How often were you out o f  the house for at least
part o f the day?           9/
3. How often were you able to do errands in the
neighborhood?           10/
4. How often did someone have to assist you to get
around outside your home. _____  _____  _____  _____  _____  11/
5. How often were you in a bed or chair for most or
all o f the day?           12/
These questions refer to WALKING AND BENDING.
All Most Some Few No
Days Days Days Days Days
0 ) (2) (3) (4) (5)
DURING THE PAST MONTH ...
6. Did you have trouble doing vigorous activities 
such as running, lifting heavy objects, or
participating in strenuous sports?           13/
7. Did you have trouble either walking several
blocks or climbing a few flights o f stairs?           14/
8. Did you have trouble bending, lifting or
stooping?           15/
9. Did you have trouble either walking one block or
climbing one flight o f  stairs?           16/
10. Were you unable to walk unless assisted by
another person or by a cane, crutches, or walker? _____          17/
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Please check (O  the most appropriate answer for each question.
These questions refer to BLAND AND FINGER FUNCTION.
DURING THE PAST MONTH...
11. Could you easily write with a pen or pencil?
12. Could you easily button a shirt or blouse?
13. Could you easily turn a key in a lock?
14. Could you easily tie a knot or a bow?
15. Could you easily open a new jar of food?
All Most Some Few No
Days Days Days Days Days
(I) (2) (3) (4) (5)
18/
19/
20/
21/
22/
These questions refer to ARM FUNCTION.
DURING THE PAST MONTH ...
16. Could you easily wipe your mouth with a 
napkin?
All Most Some Few No
Days Days Days Days Days
(I) (2) (3) (4) (5)
23/
17. Could you easily put on a pullover sweater?
18. Could you easily comb or brush your hair?
19. Could you easily scratch your low back with 
your hand?
24/
25/
26/
20. Could you easily reach shelves that were above 
your head? 27/
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Please check ( / )  the most appropriate answer for each question.
These questions refer to SELF-CARE TASKS.
Very Almost
DURING THE PAST MONTH... Always Often Sometimes Never Never
(1) (2) (3) (4) (5)
21. Did you need help to take a bath or a shower? ____          28/
22. Did you need help to get dressed?           29/
23. Did you need help to use the toilet?           30/
24. Did you need help to get in or out o f  bed? _____  _____  _____  _____  _____  31/
These questions refer to HOUSEHOLD TASKS.
Very Almost
DURING THE PAST M ONTH... Always Often Sometimes Never Never
(I) (2) (3) (4) (5)
25. If you had the necessary transportation, could
you go shopping for groceries without help?           32/
26. If you had kitchen facilities, could you prepare
your own meals with out help?           33/
27. If you had household tools and appliances, could
you do your own house work without help?           34/
28. If you had laundry facilities, could you do your
own laundry without help?           35/
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All Most Some Few No
Days Days Days Days Days
(I) (2) (3) (4) (5)
Please check the most appropriate answer for each question.
These questions refer to SOCIAL ACTIVITY
DURING THE PAST MONTH...
29. How often did you get together with friends or
relatives?           36/
30. How often did you have fnends or relatives over
to your home?           37/
31. How often did you visit friends or relatives at
their homes?           38/
32. How often were you on the telephone with close
friends or relatives?           39/
33. How often did you go to a meeting of a church,
club, team, or other group?           40/
These questions refer to SUPPORT FROM FAMILY AND FRIENDS.
Very Almost
DURING THE PAST MONTH... Always Often Sometimes Never Never
(1) (2) (3) (4) (5)
34. Did you feel that your family or friends would
be around if you needed assistance?           41/
35. Did you feel that your family or fnends were
sensitive to your personal needs?           42/
36. Did you feel that your ftmily or fnends were
interested in helping you solve problems?           43/
37. Did you feel that your family or fnends
understood the affects of your arthritis?           44/
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Please check (■<^) the most appropriate answer for each question.
These questions refer to ARTHRITIS PAIN.
DURING THE PAST M ONTH...
38. How would you describe the arthritis pain you 
usually had?
39. How often did you have severe pain from 
arthritis?
40. How often did you have pain in two or more 
joints at the same time?
41. How often did your morning stiffiiess last more 
than one hour from the time you woke up?
42. How often did yoim pain make it difticult for 
you to sleep?
Severe Moderate
(I) (2)
Mild
(3)
Very Mild None
(4) (5)
All Most Some Few No
Days Days Days Days Days
(I) (2) (3) (4) (5)
45/
46/
47/
48/
49/
These questions refer to Work.
DURING THE PAST MONTH ...
43. What has been your main form of work?
Paid
Work
( 1)
House
Work
(2)
School
Work
(3)
Unemployed Disabled Retired
(4) (5) (6)
All Most Some Few No
Days Days Days Days Days
(1) (2) (3) (4) (5)
If you answered unemployed, disabled, or retired, please skip the next four questions and go to the next page.
DURING THE PAST MONTH ...
44. How often were you able to do any paid work, 
house work, or school work?
45. On the days that you did work, how often did 
you have to work a shorter day?
46. On the days that you did work, how often were 
you unable to do your work as carefully and 
accurately as you would like?
47. On the days that you did work, how often did you 
have to change the way your paid work, house 
work, or school work is usually done?
50/
51/
52/
53/
54/
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Please check Ûie most ^ propriate answer for each question.
These questions refer to LEVEL OF TENSION.
DURING THE PAST MONTH...
Very Almost
Always Often Sometimes Never Never
(1) (2) (3) (4) (5)
48. How often have you felt tense or high strung?
49. How often have you been bothered by 
nervousness or your nerves?
50. How often were you able to relax without 
difficulty?
51.- How often have you felt relaxed and ftee of 
tension?
52. How often have you felt calm and peaceful?
55/
56/
57/
58/
59/
These questions refer to MOOD.
DURING THE PAST MONTH ...
53. How often have you enjoyed the things you do?
54. How often have you been in low or very low 
spirits?
55. How often did you feel that nothing turned out 
the way you wanted it to?
56. How often did you feel that others would be 
better o ff if you were dead?
57. How often did you feel so down in the dumps 
that nothing would cheer you up?
Always
(I)
Very
Often
(2)
Sometimes
(3)
Almost
Never
(4)
Never
(5)
60/
61/
62/
63/
64/
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Please check (^O &e most appropriate answer for each question.
These questions refer to satisfaction with each health area.
Neither
Satisfied Somewhat Very
DURING THE PAST MONTH... Very Somewhat Nor Dis- Dis- Dis­
satisfied Satisfied satisfied satisfied satisfied
(1) (2) (3) (4) (5)
58. How satisAed have you been with each o f 
these areas o f  your health?
MOBILITY LEVEL
(example; do errands)           65/
WALKING AND BENDING
(example: climb stairs)           66/
HAND AND FINGER FUNCTION
(example: tie a bow)           67/
ARM FUNCTION
(example: comb hair)_______________________________________     . _     68/
SELF-CARE
(example: take bath)           69/
HOUSEHOLD TASKS
(example: housework)           70/
SOCIAL ACTIVITY
(example: visit fnends)           71/
SUPPORT FROM FAMILY
(example: help with problems)           72/
ARTHRITIS PAIN
(example: joint pain)           73/
WORK
(example: reduce hours)           74/
LEVEL OF TENSION
(example: felt tense)           75/
MOOD
(example: down in dumps)           76/
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ID 1-4/ 
Adnrf 5-6/ 
Card #2 7/ 
AIMS
Please check (^ )  the most appropriate answer for each question. 
These questions refer to arthritis impact on each area o f  health.
DURING THE PAST MONTH ...
59. How much o f  your problem in 
each area o f health was due to 
your arthritis?
MOBILITY LEVEL 
(example: do errands)
WALKING AND BENDING 
(example: climb stairs)
HAND AND FINGER FUNCTION 
(example: tie a bow)
ARM FUNCTION 
(example: comb hair)
SELF-CARE 
(example: take bath)
HOUSEHOLD TASKS 
(example: housework)
SOCIAL ACTIVITY 
(example; visit friends)
SUPPORT FROM FAMILY 
(example: help with problems)
ARTHRITIS PAIN 
(example: joint pain)
WORK
(example: reduce hours)
LEVEL OF TENSION 
(example: felt tense)
MOOD
(example: down in dumps)
Due Due
Due Partly 
to Arthritis Due Due
N ota Entirely Largely and Partly Largely Entirely
Problem To Other To Other to Other To My To My
For Me Causes Causes Causes Arthritis Arthritis
(0) (I) (2) (3) (4) (5)
8/
9/
10/
11/
12/
13/
14/
15/
16/
17/
18/
19/
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You bave now answered questions about different AREAS OF YOUR HEALTH. These areas are listed below. Please 
check ( / )  up to THREE AREAS in which you would MOST LIKE TO SEE IMPROVEMENT. Please read all 12 areas o f 
health choices before making your decision:
Check = 1 
Blank = 0
60. AREAS OF HEALTH THREE AREAS FOR IMPROVEMENT
MOBILITY LEVEL 
(example: do errands) 20/
WALKING AND BENDING 
(example: climb stairs) 21/
HAND AND FINGER FUNCTION 
(example: tie a bow) 22/
ARM FUNCTION 
(example: comb hair) 23/
SELF-CARE 
(example: take bath) 24/
HOUSEHOLD TASKS 
(example: housework) 25/
SOCIAL ACTIVITY 
(example: visit fnends) 26/
SUPPORT FROM FAMILY 
(example: help with problems) 27/
ARTHRITIS PAIN 
(example: joint pain) 28/
WORK
(example: reduce hours) 29/
LEVEL OF TENSION 
(example: felt tense) 30/
MOOD
(example: down in dumps) 31/
Please make sure that you have checked no more than THREE AREAS for improvement
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Please check (^ ) the most appropriate answer for each question.
These questions refer to your CURRENT and FUTURE HEALTH.
Excellent
( 1)
61. In general would you say that your HEALTH NOW is 
excellent, good, fair, or poor?
Good
(2)
Fair
(3)
Poor
(4)
32/
62. How satisfied are you with your 
HEALTH NOW?
Very Somewhat
Neither 
Satisfied 
Nor Dis­ Somewhat Very Dis­
Satisfied Satisfied satisfied Dissatisfied satisfied
(1) (2) (3) (4) (5)
Due Due
Due Partly 
to Arthritis Due Due
Nota Entirely Largely and Partly Largely Entirely
Problem To Other To Other to Other To My To My
For Me Causes Causes. Causes Arthritis Arthritis
(0) (1) (2) (3) (4) (5)
63. How much o f your problem 
with your HEALTH NOW is 
due to your arthritis?
33/
34/
Excellent
(0
64. In general do you expect that your HEALTH 10
YEARS FROM NOW will be excellent, good, fair, or 
poor?
Good
(2)
Fair
(3)
Poor
(4)
35/
No Problem Minor Moderate Major
At All Problem Problem Problem 
(1) (2) (3) (4)
65. How big a problem do you expect your arthritis to be 
10 YEARS FROM NOW? 36/
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Please check (y )  the most appropriate answer for each question
This question refers to OVERALL ARTHRITIS IMPACT.
Very Well Well Fair Poor Very Poorly 
(1) (2) (3) (4) (5)
66. CONSIDERING ALL THE WAYS THAT 
YOUR ARTHRITIS AFFECTS YOU. how 
well are you doing compared to other people
your tige?           37/
What is the main kind o f arthritis that you have? Check = I
Blank = 0
Rheumatoid Arthritis   38/
Osteoarthritis/Degenerative Arthritis   39/
Systemic Lupus Erythematosis   40/
Fibromyalgia   41/
Scleroderma   42/
Psoriatic Arthritis   43/
Reiter’s Syndrome   44/
Gout   45/
Low Back Pain   46/
Tendonitis/Bursitis   47/
Osteoporosis   48/
Other   49/
68. How many years have you had arthritis?   50-51/
All Most Some Few No
Days Days Days Days Days
(I) (2) (3) (4) (5)
DURING THE PAST MONTH...
69. How often have you had to take MEDICATION
for your arthritis?           52/
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Please check (^ ) yes or no for each question.
70. Is your health currently affected by any of the following medical problems?
Yes No
(I) (2)
High blood pressure_________________________________      53/
Heart disease______________________________________      54/
Mental illness______________________________________      55/
Diabetes__________________________________________      56/
Cancer___________________________________________      57/
Alcohol or drug u s e _________________________________      58/
Lung disease_______________________________________      59/
Kidney disease_____________________________________      60/
Liver disease_______________________________________      61/
Ulcer or other stomach disease________________________      62/
Anemia or other blood disease_________________________________  63/
Yes No
( 1) (2)
71. Do you take medicine every day for any problem other than
your arthritis?     64/
Yes No
(I) (2)
72. Did you see a doctor more than three times last year for any
problem other than arthritis?      65/
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Please provide the fcliowing information about yourself:
73. What is your age at this time?   66-67/
74. What is your sex?
Male (1)   68/
Female (2)_________________________________________________ _____
75. What is your racial background?
White (I)   69/
Black (2)________________________________________________________
Hispanic (3)________________________________________________ _____
Asian or Pacific Islander (4) _____
American Indian or Alaskan Native (5) _____
Other (6) _____
76. What is your Current marital status?
Married (1)   70/
Separated (2)_______________________________________________ _____
Divorced (3)_____________________________________________________
Widowed (4)_______________________________________________ _____
Never married (5) _____
77. What is the highest level of education you received?
Less than seven years o f school (1)   71/
Grades seven through nine (2) _____
Grades ten through eleven (3) _____
High school graduate (4) _____
One to four years o f  college (5) _____
College graduate (6) _____
Professional or graduate school (7)_____________________________ _____
78. What is your approximate family income including wages, disability payment, 
retirement income, and welfare?
Less than $10,000 (I)   72/
$ 10,000 - $ 19,999 (2) _____
$20,000 - $29,999 (3) _____
$30,000 - $39,999 (4) _____
$40,000 - $49,999 (5) _____
$50,000 - $59,999 (6) _____
$60,000 - $69,999 (7) _____
More than $70,000 (8)_______________________________________ _____
Thank you fo r  completing this questionnaire.
Reprinted with Permission. Meenan, Robert F. The Arthritis Impact Measurement Scales. yowna/q/’/Z/icumaro/gy. 1982, Revised 
1991. 9:785-788.
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Appendix B
A tte n t io n  A r th r i t i s  S u f f e r e r s
I f  a  p h y s ic i a n  h a s  d ia g n o s e d  y o u  w i t h  O s te o a r th r i t i s  in  o n e  o r  
b o th  o f  y o u r  k n e e s  y o u  m a y  b e  e l ig ib le  t o  p a r t i c ip a t e  in  a n  e x c i t i n g  
n e w  s tu d y  t h a t  is  b e in g  c o n d u c te d  t h r o u g h  G r a n d  V a lle y  S ta te
U n iv e r s i ty .
T h e  p u r p o s e  o f  th i s  s tu d y  is  to  e x p l o r e  a l te r n a t iv e  t r e a tm e n ts  
s u c h  a s  n u t r i t io n a l  s u p p le m e n ta t io n  a n d  e x e r c i s e  o n  d e c r e a s in g  p a i n  
f r o m  a r th r i t i s  o f  th e  k n e e .  W e  a re  l o o k in g  f o r  m e n  a n d  w o m e n  w h o  
a r e  o v e r  4 0  y e a r s  o f  a g e . I f  y o u  w o u ld  l i k e  m o r e  in fo rm a t io n  a b o u t
th i s  s tu d y
please call Dan Schaffer and Anna Power at 1-800-797- 
6046.
Osteoarthritis is a disease that destroys the cartilage in the weight bearing 
joints o f the body such as knees, hips, ankles and back. With Osteoarthritis, the 
body is not able to rebuild cartilage at the same rate that it is being destroyed By 
providing the correct nutrition the body can improve i t ’s ability to rebuild 
cartilage and decrease pain.
Unfortunately you will NOT be eligible if
• You have a diagnosis o f Diabetes or Peripheral Vascular Disease
• You are currently consuming nutritional supplementation such as; chondroitin sulfate 
glucosamine sulfate or gelatin
•  If  you cannot walk for 20 minutes without stopping
• If you are currently involved in any lower extremity exercise program that you 
participate in 3 or more times a week for 1S minutes or more at a time. (Walking,
Biking, Running)
• Loss o f feeling in your legs
49
Appendix C 
Subject Questionnaire
Circle the Appropriate Response
1. Have you been diagnosed by a physician as having Osteoarthritis YES NO
or Degenerative Joint Disease o f  one or both knees?
2. Have you ever been diagnosed with Diabetes or Peripheral YES NO
Vascular Disease?
3. Do you ciurently have any numbness or loss o f  feeling YES NO
in either of your legs?
4. Do you currently have any uiuresolved problems with your YES NO
knees other than Osteoarthritis or Degenerative Joint Disease?
If yes, please explain:_____________________________________
5. Are you currently taking any nutritional supplements such as YES NO
vitamins. Glucosamine sulfate, chondroitin sulfate, Nutrajoint or minerals?
If yes, what are you taking?________________________________
6. Are you able to walk for 15 minutes continuously without difficulty? YES NO
7. Do you perform any type of exercise including walking on a regular YES NO
basis. If  yes, please describe what exercise you do, how much
time it involves per week and the number o f times per week that it 
is performed.___________________________________
Please Print:
Name (first and last)______________________
Mailing Address ______________________
Social Security Number Home Phone ( )_
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Day
Sat.
Date
Appendix D
Daily Log for Exercise and Nutritional Supplementation Groups
Sun Mon. Tues. Wed Thurs. Friday
Consum
ed
Powder
Walked
(record
time)
Amount
o f
Pain/anti
inflamm
atory
Medicati
on
# o f
drinks
containi
ng
caffeine
++
Pain
rating
(0-10)
0 = no 
pain 
10= 
worst 
pain 
possible
Calcium
rich
foods
consume
d**
**Calcium rich foods consumed include:
-H-Caffeine Containing foods include:
I c. Milk,
Ic. yogurt,
I slice of cheese 
1 bowl ice cream.
I c. Tea 
I c. Coffee
I can o f  coke/Pepsi/mcimtain dew.
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Daily Log for Nutritional Supplementation only groups
Day Sun Mon. Tues. Wed Thurs. Friday
Sat 
Date
Consum
ed
Powder
Amount
o f
Pain/anti
inflamm
atory
Medicati
on
# o f
drinks
containi
ng
caffeine
++
Pain
rating
(0-10)
0 = no 
pain 
10= 
worst 
pain 
possible
Calcium
rich
foods
consume
d**
♦♦Calcium rich foods consumed include: 1 c. Milk,
Ic. yogurt,
1 slice o f cheese 
1 bowl ice cream.
-H-Caffeine Containing  foods include: 1 c. Tea 
1 c. Coffee
1 can o f coke/Pepsi/mountain dew.
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A rth ritis In form ation
T h a n k  y o u  f o r  y o u r  in t e r e s t  in  o u r  s tu d y .  A l th o u g h  y o u  c a n n o t  
p a r t i c ip a te ,  w e  w o u ld  l ik e  t o  s h a r e  s o m e  in f o r m a t io n  th a t  m a y  b e  
h e lp f u l  f o r  y o u .
T h e s e  a r e  s o m e  th in g s  t h a t  y o u  m a y  w a n t  t o  t ry :
1. Glucosamine Sulfate
2. chondroitin Sulfate
T h e s e  s u p p le m e n ts  c a n  b e  f o u n d  in  m a n y  h e a l th  fo o d  s to r e s .  T h e y  
a r e  a n  im p o r ta n t  c o m p o n e n t  o f  t h e  c a r t i l a g e  in  y o u r  j o i n t .  M a n y  
p e o p le  h a v e  n o t ic e d  a  d e c r e a s e  in  p a i n  a f t e r  u s in g  th e s e  f o r  a t  l e a s t  2 -  
4  w e e k s .
3. Knox Gelatin or Knox Nutraioint®
T h is  p r o d u c t  c a n  b e  f o u n d  in  t h e  g e l a t i n  a i s l e  o f  m a n y  g r o c e r y  s to r e s .  
I t  c o n ta in s  th e  a m in o  a c id s  t h a t  a r e  u s e d  to  b u i l d  T y p e  2  c a r t i la g e ,  
w h ic h  is  im p o r ta n t  f o r  y o u r  j o i n t .  M a n y  p e o p l e  h a v e  e x p e r i e n c e d  a  
d e c r e a s e  in  p a in  a f t e r  t a k in g  t h i s  d a i l y  f o r  2 - 4  w e e k s .  T h e  
r e c o m m e n d e d  d o s a g e  is  o n  t h e  c o n ta in e r ;  o n e  s c o o p  d a i ly .
4. Vitamin C supplements
S o m e  p e o p le  r e c o m m e n d  t a k i n g  V i ta m in  C  b e c a u s e  i t  is  u s e d  w h e n  
th e  b o d y  is  t r y in g  to  m a k e  t y p e  2  c a r t i l a g e .  I f  y o u r  d ie t  i s  lo w  in  
V i ta m in  C  ( i f  y o u  d o n ’t  e a t  m a n y  f r u i t s  o r  d r in k  ju i c e  o f te n ) ,  i t  m a y  
a f f e c t  t h e  s t r e n g th  o f  th e  c a r t i l a g e  in  y o u r  j o i n t .
5. Calcium supplements
C a lc iu m  is  im p o r ta n t  f o r  s t r o n g  b o n e s .  I f  y o u r  b o n e s  a r e n ’t  s t r o n g ,  i t  
c o u ld  a f f e c t  h o w  s t r o n g  y o u r  j o i n t s  a r e .  I f  y o u  d o  n o t  c o n s u m e  m a n y  
d a i r y  p r o d u c ts ,  o r  i f  y o u  d r in k  a  l o t  o f  c a f f e in a te d  p ro d u c ts ,  y o u  m a y  
b e n e f i t  f r o m  c a lc iu m  s u p p le m e n ts .
6. Antioxidants
T h e s e  s u p p le m e n ts  m a y  h e lp  p r o t e c t  th e  c a r t i l a g e  in  y o u r  j o i n t  f r o m  
b e in g  d e s t r o y e d  b y  f r e e  r a d ic a l s .  A n t io x i d a n t s  in c lu d e  V i ta m in  A , 
V i ta m in  C , V ita m in  E , a n d  S e le n iu m .
7. Exercise
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L a te ly ,  r e s e a rc h e r s  h a v e  r e a l i z e d  t h a t  a  c e r ta in  a m o u n t  o f  e x e r c is e  3 -  
5 x  a  w e e k  m a y  b e  h e lp f u l  in  m a in ta i n in g  h e a l th y  c a r t i l a g e  f o r  y o u r  
j o i n t s .  M a n y  p e o p le  w i th  A r th r i t i s  h a v e  fo u n d  th a t  e x e r c i s e  in  
m o d e ra te  a m o u n ts  s u c h  a s  w a lk i n g  o r  s w im m in g  h a s  h e lp e d  r e l ie v e  
s o m e  o f  th e ir  p a in .  S p e c i f ic  e x e r c i s e s  f o r  th e  j o i n t  h a v e  a l s o  r e l ie v e d  
p a i n  in  so m e  in d iv id u a ls .  I t  i s  im p o r ta n t  th a t  y o u  d is c u s s  n e w  e x e rc is e  
p r o g r a m s  w ith  y o u r  d o c to r .
8 .  W e i g h t  L o s s
I f  y o u  h a v e  a r th r i t i s  in  y o u r  le g s  a n d  y o u  a r e  o v e rw e ig h t ,  y o u r  jo i n t s  
a r e  w o rk in g  e x t r a  h a r d .  B y  lo s in g  w e ig h t ,  y o u  a re  d e c r e a s in g  th e  
a m o u n t  o f  fo rc e  th a t  is  g o in g  th r o u g h  y o u r  c a r t i la g e . I t  m a y  b e  
h e lp f u l  to  s p e a k  to  y o u r  d o c to r  i f  y o u  w is h  to  s ta r t  a  w e ig h t  lo s s  
p r o g r a m .
These are some things that you may want to try. If your doctor has 
prescribed something for your arthritis, these things may be tried, but 
DON’T stop doing what you are already doing without speaking to 
your doctor. I f  you are thinking o f  trying nutritional supplements, 
talk to your doctor, a certified nutritionist, or your pharmacist about 
what dosage would be most appropriate for you.
It is usually recommended that you try one new thing at a time, so 
that you can decide what is helpful for you. This is only a partial list, 
new research is being conducted all the time to find the best way to 
treat Arthritis.
Most o f the information found here can be found in the book The 
Arthritis Cure by Jason Theodosakis and Brenda Adderly (1997) 
published by St. Martins Paperbacks, NY, NY. If you want more 
detailed information this may be a good place to start.
Another great resource is The Arthritis Foundation. In Grand Rapids the number 
is (616) 774-873
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Consent Form
You are invited to participate in a research study entitled The Effects of 
Nutritional SuDolementation and Exercise on Subjective Pain and Function 
in Osteoarthritis of the Knee. This purpose of this study is to investigate the 
effects o f Knox Nutrajoint®, Maltodextrin and walking on Osteoarthritis. This 
study is being conducted through the Grand Valley State University Physical 
Therapy program. Dan Scheffer and Anna Power are the principal investigators 
for this research and it is being funded by the Nabisco Corporation. Nabisco will 
provide the Knox Nutrajoint and Maltodextrin as well as all mailing materials free 
of charge.
In order to be included in this studv: 
you must be above 40 years of age
you must be able to walk for 15 minutes at a time without supervision.
you must have doctor diagnosis of Osteoarthritis or Degenerative Joint Disease in one or both
knees
You will be excluded from this studv:
If you have had joint replacement surgery in both o f your Osteoarthritis knees
If you have had &actures or tendon tears within the last 90 days in your Osteoarthritis knee(s).
If you have been diagnosed with Diabetes of Peripheral Vascular Disease.
If you are unable to walk for 15 minutes at a time without supervision
If you have been exercising your legs at least 3x a week, 15 minutes at a time (such as water
aerobics, aerobics, walking, biking).
You will be randomly assigned to one of the following four groups ( a process 
similar to flipping a coin).
A. Walking 3x a week and drinking maltodextrin daily
B. Walking 3x a week and drinking Knox Nutrajoint daily
C. Drinking maltodextrin daily
D. Drinking Knox Nutrajoint daily
You will not be told if you are receiving Maltodextrin or Knox Nutrajoint. 
Likewise, the researchers will not know which group you are in until the end o f 
the study.
Knox Nutrajoint -  40 Calories Maltodextrin -  40 Calories
lOg Gelatin (protein) lOg Maltodextrin (carbohydrate)
300mg Calcium, 30% RDA Dietetic Cloud
60mg Vitamin C, 100%RDA Artificial Colors
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1. The study will last for 8 consecutive weeks.
2. You will have to complete a 15 minute written questionnaire regarding pain 
and function before and after the study as well as maintain a daily written log.
3. Your physician will have to confirm your diagnosis of Osteoarthritis or 
degenerative joint disease o f one or both knees by signing a form before you 
begin participation in this study.
4. The information you provide throughout the course of this study will remain 
confidential to the extent permitted by law. Dan Scheffer and Anna Power are the 
only people allowed access to the data pertinent to this study. Your identity will 
not be disclosed without written consent in any publications resulting firom this 
research project.
5. You may experience a decrease in knee pain during the 8-week study.
6. A very small percent%e of people have experienced minor gastrointestinal 
discomfort (gas, bloating) with the consumption of gelatin due to it’s protein.
7. By participating in this study there is a possibility that the knee pain may 
increase temporarily if  you are assigned to one of the exercise groups.
8. The results of this study will be made available to you at the end o f  the study 
through a mailing.
9. During this study we ask that you not add glucosamine sulfate, chondroitin 
sulfate to your diet or change your nonnal eating habits.
10. You are one o f at least 100 volunteers participating in this study.
11 .Knox Nutrajoint and Maltodextrin as well as other nutritional supplementation 
are available at any grocery store if you wish to try these instead of participating 
in this study.
12. Participation in this study is voluntary and you may withdraw a t anytime 
without any repercussions by contacting either Dan Scheffer or Anna Power by 
phone at 1-800-797-6046.
13. If  the researchers feel it necessary for you to discontinue with the program 
they may do so without your consent. Reasons for discontinuation may include, 
but are not limited to, gastrointestinal discomfort with Nutrajoint or excessive 
pain with exercise.
14. You will be informed if  significant new findings become available, during this 
study, that may affect your willingness to continue to participate in this study.
15. A copy of the signed consent form will be given to you.
16. If  you are a woman o f child bearing age or think that you are pregnant, you 
should consult with you physician prior to entering this study.
17. You will be phoned at weeks 1,4, and 8 o f the study to ask if  you have any 
questions as you will be going through the program independently.
Please Initial
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I acknowledge that:
A researcher has personally gone over this consent form with me and 
given me the opportunity to ask questions about this research study. I also feel 
that my questions have been answered to my satisfaction. If  I have any questions 
during the study I can phone Dan Scheffer at 1-800-797-6046 or Robert 
Henderson, chair of Human Subjects review Board a t G rand Valley State 
University a t (616) 895-2195.
I hereby authorize the researchers to release the information obtained in this 
study to scientific literature. I have been informed that my name will not be 
identified and that all information that I have provided will remain confidential.
I acknowledge that I have read and understand the above information and that I 
agree to participate in this study.
(Participant Signature) (Wimess)
Date Date
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Physicians Confirmed Diagnosis
Dear Dr.
I _______________ give Dr._____________ permission to release
information
(patient’s signature) (print )
from my medical records pertaining the diagnosis o f Osteoarthritis/Degenerative 
Joint Disease for the purpose o f research.
I am currently involved in a study on Osteoarthritis with graduate students 
and faculty from the Grand Valley State University Physical Therapy program.
In order to participate in this study I m ust have your confirmation that I 
have Osteoarthritis/ Degenerative Joint Disease of one or both knees. Could 
you please confirm my diagnosis and send this letter back to the researchers 
in the stamped envelope that I have provided. This study will last for eight 
weeks and will look at the effect of a progressive walking program and Nabisco’s 
Knox Nutrajoint on the symptoms of Osteoarthritis. Knox Nutrajoint can be 
purchased at any large food store and contains 10 grams of gelatin (protein). 
Calcium, and Vitamin C. Maltodextrin will also be used as a carbohydrate 
supplement containing com starch and artificial colors. The data will be collected 
with the Arthritis Impact Measurement Scale 2 taken both before and after the 8- 
week protocol. 1 will be randomly assigned to one o f four groups. Group one will 
walk for up to 30 minutes 3 times per week and consume Knox Nutrajoint. Group 
two will only consume Knox Nutrajoint. Group three will walk for up to 30 
minutes 3 times per week and consume maltodextrin. Group four will only 
consume maltodextrin. The maltodextrin and Knox Nutrajoint will be in powder 
form and mixed into a fruit juice for consumption once a day. Thank you for your 
time.
I________________ confirm that________________ was diagnosed with
Osteoarthritis
(Physician’s Signature) (Patient’s Name)
of his or her____________ knee(s). Date_________
(Left, Right 3oth)
If the Doctor has any questions please feel free to call the researchers:
Dan Scheffer 1-800-797-6046
or Robert Hendersen, chair o f GVSU Human Subjects Review Board at (616) 
895-2195
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Instruction sheet for group 1 and 3
1. Fill out and sign the letter to you doctor requesting your diagnosis of 
Osteoarthritis or Degenerative Joint Disease.
2. Put the doctor’s letter in the large yellow envelope along with the stamped 
envelope addressed to Dan Scheffer marked “Doctor” on the back.
3. Every day you will be mixing one pouch of the powder given to you into at 
least 8 ounces o f your favorite juice drink. It is important that you consume this 
think 15 minutes to an hour before you exercise.
4. It is important to walk for the designated amount of time three times a week. 
Use the table to determine how long you need to walk each week. Try to walk 
Monday, Wednesday and Friday or Tuesday, Thursday, and Saturday. This way 
your body will get a day of rest between exercise.
Week # U of  days a wk* walking time (minutes)
1 3 15
2 3 20
3 3 25
4 3 30
5 3 30
6 3 30
7 3 30
8 3 30
*the three weekly walking sessions should be spread out through the week
5. Evciy day fill out your logbook.
6. At the end o f 8 weeks immediately fill out the Arthritis Impact Measurement 
Scale 2 **Please make sure that every question is answered, even if  it does not 
seem to apply to your condition.
1. After completing the Arthritis Impact Measurement Scale 2 put it in the large 
stamped envelope marked “DONE” and mail.
8. If you run out of powder or you have and questions please call Dan Scheffer at 
1-800-797-6046.
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Instruction Sheet for Groups 2 and 4
1. Fill out and sign the letter to you doctor requesting your diagnosis of 
Osteoarthritis or Degenerative Joint Disease.
2. Put the doctor’s letter in the large yellow envelope along with the stamped 
envelope addressed to Dan Scheffer marked “Doctor” on the back.
3. Every day you will be mixing one pouch o f the powder given to you into at 
least 8 ounces of your favorite juice drink. Try to drink this mixture in the 
morning.
4. Every day fill out your logbook.
5. At the end of 8 weeks immediately fill out the Arthritis Impact Measurement 
Scale 2
**Please make sure that every question is answered^ even if  it does not seem to 
apply to your condition,
6. After completing the Arthritis Impact Measurement Scale 2 put it in the large 
stamped envelope marked “DONE” and mail.
7. If you run out of powder or you have and questions please call Dan Scheffer at 
1-800-797-6046
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Research Assistant instructions
Phone calls to Subjects
1. E a c h  s u b je c t  is  t o  b e  c a l le d  a t  w e e k s  1, 4 ,  a n d  8.
2 .  I n t r o d u c e  y o u r s e l f  a s  a n  a s s i s t a n t  in  t h e  a r th r i t i s  s tu d y .
3 . A s k  th e  s u b je c t  i f  t h e y  w e r e  m i x in g  th e i r  p o w d e r e d  s u p p le m e n t  
in to  a  l iq u id  a n d  d r in k in g  i t  o n c e  p e r  d a y .
3 a .  I f  t h e  s u b je c t  w a s  in  a n  e x e r c i s e  g r o u p ,  a s k  h o w  o f te n  t h e y  w e re  
w a lk in g .
4 .  A s k e d  i f  th e r e  a r e  a n y  q u e s t io n s  o r  p r o b le m s  th a t  n e e d e d  t o  b e  
a d d r e s s e d .
5 .  T h a n k  e a c h  s u b je c t  f o r  p a r t i c ip a t in g  in  t h e  s tu d y .
6 . I f  t h e  s u b je c t s  h a v e  q u e s t io n s ,  c o n ta c te d  th e  p r im a ry  r e s e a r c h e r s  
D S  a n d  A P . D S  o r  A P  w i l l  c a l l  t h e  s u b je c t  a n d  a n s w e r  a n y  q u e s t io n s  
a n d  o r  m a i l  t h e  s u b je c t  a d d i t io n a l  s u p p le m e n ts  i f  n e e d e d .
W e e k  4
1. F o l lo w  a b o v e  s te p s  1 -6
2 . R e m in d  s u b je c t  t o  m a i l  in  t h e i r  c o n f i r m a t io n  o f  a  d ia g n o s i s  o f  
o s t e o a r th r i t i s  i f  th e y  h a d  n o t  a l r e a d y  d o n e  s o .
W e e k s
1. R e m in d  s u b je c ts  to  in c lu d e  t h e i r  lo g  s h e e ts  a n d  A IM S 2  s u r v e y s  in  
th e  e n v e lo p e  th a t  th e y  m a i l  b a c k  t o  th e  p r im a r y  r e s e a r c h e r s .
Note: After the log sheets and the tests were received in the mail 
each subject was called by an unblinded research assistant CS. CS 
called each subject and revealed which nutritional supplementation 
group they were in. Each subject was then thanked again for  
participating in the research study.
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